Advertisement

Topics

Infant Bacterial Therapeutics AB IBT B Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

23:25 EST 13 Nov 2017 | BioPortfolio Reports

Summary


Infant Bacterial Therapeutics AB IBT, a subsidiary of BioGaia AB is a pharmaceutical company that develops prophylactic therapies for the medical needs of the premature infant. The company develops pharmaceutical drug candidates for gastrointestinal neonatal condition that causes mucosal injury, necrosis, perforation in the intestinal tracts of infants and death. It offers its products for treating necrotizing enterocolitis, a medical condition primarily seen in premature infants, where portions of the bowel undergo necrosis. IBT's IBP9414 drug candidate, containing a coevolved human bacterial strain derived from human breast milk, is used for the prevention of NEC in premature infants. The company's IBP1016 drug candidate is used for the treatment of an unmet medical need in gastroschisis. It operates through a network of neonatologists and research groups. IBT is headquartered in Stockholm, Sweden.


Infant Bacterial Therapeutics AB Key Recent Developments


Aug 28,2017: Infant Bacterial Therapeutics: Interim Management Statement, January 1 June 30, 2017

May 04,2017: Infant Bacterial Therapeutics: Interim Management Statement, January 1 March 31, 2017

Feb 14,2017: Infant Bacterial Therapeutics Interim report January 1 December 31 2016

Oct 12,2016: Infant Bacterial Therapeutics appoints new CFO

Sep 02,2016: IBT welcomes new Business Analyst


This comprehensive SWOT profile of Infant Bacterial Therapeutics AB provides you an indepth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.


This company report forms part of GlobalData's Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Infant Bacterial Therapeutics AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. excluding weekends.


The profile contains critical company information including*,


Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.


Note*: Some sections may be missing if data is unavailable for the company.


Key benefits of buying this profile include,


You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.


Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.


Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.


Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.


Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Original Article: Infant Bacterial Therapeutics AB IBT B Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

NEXT ARTICLE

More From BioPortfolio on "Infant Bacterial Therapeutics AB IBT B Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...